Tci Wealth Advisors, Inc. Harmony Biosciences Holdings, Inc. Transaction History

Tci Wealth Advisors, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	SELL	$30.8 - $53.92 $1,540 - $2,696	-50 Reduced 29.94%	117 $3,000
Q4 2022 Feb 06, 2023	BUY	$45.4 - $60.91 $2,270 - $3,045	50 Added 42.74%	167 $9,000
Q2 2022 Jul 19, 2022	BUY	$33.54 - $52.15 $1,173 - $1,825	35 Added 42.68%	117 $6,000
Q2 2021 Aug 02, 2021	BUY	$25.96 - $33.44 $2,128 - $2,742	82 New	82 $2,000

254

46.6M

119K

50K

Ticker HRMY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,161,400
Market Cap $2.02B
Description
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.